Because cyclin D1 is induced with an exogenous source of AGR2 (Figure 4) and reduced with an anti-AGR2 Ab (Figure 7), and AGR2 is detected in the supernatant of breast cancer cell lines, it suggests that AGR2 may have an extracellular mechanism of action. Here, AGR2 is linked to breast carcinoma.